Tag: Price Negotiations

Lexus Complete Lease Program | Digital Trends

Lexus Complete Lease Program | Digital Trends

“We talked about starting it nationwide but we wanted to get a sense of how this would play out. Our plan is to test it [in urban areas], and if we’re successful we will look at rolling it out nationally,” Cynthia Tenhouse, Lexus’ general manager of product and consumer marketing, explained. Lexus designed Complete Lease […]

Trump Eyeing ‘Disruptive’ Changes to Drug Pricing, Azar Says | Bloomberg

Trump Eyeing ‘Disruptive’ Changes to Drug Pricing, Azar Says | Bloomberg

The Trump administration is looking to make “disruptive” changes to U.S. drug pricing to bring down costs for patients, Health and Human Services Secretary Alex Azar said. “Every player in the system has their share of blame,” Azar said in an interview at Bloomberg headquarters in New York on Wednesday, adding that he’s working on […]

American Hospital Association suing HHS over delay in implementing drug pricing rule for 340B | Healthcare Finance News

American Hospital Association suing HHS over delay in implementing drug pricing rule for 340B | Healthcare Finance News

The American Hospital Association and America’s Essential Hospitals have joined five other 340B stakeholders in a lawsuit against the Department of Health and Human Services over its delay in implementing a final rule for drug pricing transparency that includes monetary penalties for overcharging. HHS has delayed implementation five times. Congress in 2010 gave HHS the […]

Rush to end drug rebates may be bad for patients, payers, and pharma | STAT

Rush to end drug rebates may be bad for patients, payers, and pharma | STAT

In a recent interview with Reuters, Azar said that the “question of rebates may very well be fundamental to the issue of how you reverse these constant incentives to higher list prices” for medicines. He believes that, because health plans and pharmacy benefit managers profit by keeping some of the rebates, they are happy to […]

Better Population Health Begins with Price Transparency | Medecision

Better Population Health Begins with Price Transparency | Medecision

Addressing the growing prevalence of chronic illness and continually rising costs in today’s U.S. health system isn’t easy. Fortunately, population health initiatives that aim to improve care quality while driving down the cost of care are changing the outlook. One increasingly urgent concern and key challenge that needs to be addressed is price transparency. Whether […]

Hospitals are fed up with drug companies, so they’re starting their own | The Washington Post

Hospitals are fed up with drug companies, so they’re starting their own | The Washington Post

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a mission-driven, not-for-profit generic drug company, Civica Rx, to take some control over the drug supply. Backed by seven large health systems and three philanthropic groups, the new venture will be led by an […]

Adoption grows for Allscripts cutting edge Prescription Price Transparency Solution | Globe Newswire

Adoption grows for Allscripts cutting edge Prescription Price Transparency Solution | Globe Newswire

CHICAGO, Sept. 05, 2018 (GLOBE NEWSWIRE) — Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, is delivering comprehensive prescription price information directly into the clinicians’ workflow. Allscripts Prescription Price Transparency (PPT) empowers physicians and their patients with real-time comprehensive drug price information, at the point of patient care, designed to optimize the clinical […]

Why there’s no surprise hospital bill backlash — yet | Axios

Why there’s no surprise hospital bill backlash — yet | Axios

Investigative projects from Kaiser Health News/NPR and Vox have exposed pernicious billing practices from hospitals and doctors that have left patients shocked, angered and exasperated. The bottom line: Hospitals have taken PR hits with the airing of surprise bills, but nothing suggests their practices will change in the short term. Driving the news: The $109,000 […]

Alnylam gets EU nod for Onpattro amid pricing backlash | PMLiVE

Alnylam gets EU nod for Onpattro amid pricing backlash | PMLiVE

Alnylam’s gene-silencing drug Onpattro has been approved for the rare disorder hereditary transthyretin-mediated (hATTR) amyloidosis in Europe – but celebrations will be muted by ongoing debate about its price. The  EMA has cleared Onpattro (patisiran) – the first RNA interference drug approved in the EU – for adult hATTR amyloidosis patients with stage 1 or 2 […]

Refining Price Transparency Tools to Increase Patient Use, Cut Costs | Patient Engagement HIT

Refining Price Transparency Tools to Increase Patient Use, Cut Costs | Patient Engagement HIT

August 27, 2018 – With patient financial responsibility posing a challenge throughout the healthcare industry, more healthcare experts are looking to price transparency to help patients make healthcare decisions and potentially decrease healthcare costs. Healthcare price transparency tools have already made their mark on the healthcare industry, with policymakers agreeing that they are essential to the […]